Cytotherapy Editorial Board


Cytotherapy is the official journal of ISCT.

Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion pieces on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians and regulatory experts involved in cell processing and therapy.

The journal's scope includes research in the following:

  • Stem cell processing and transplantation
  • Cell-based therapies of malignant and non-malignant blood diseases
  • Cancer
  • Stem cell plasticity
  • Autoimmune diseases
  • Immunotherapy
  • Congenital disorders
  • Novel molecular therapies
  • Gene therapy
  • Microvesicle biology and therapeutic application

Readership and Target Group

Cytotherapy provides essential reading for scientists, physicians, technicians and regulatory experts involved in cell processing and therapy. It is a vital resource for hematologists, oncologists and immunologists, and the growing number of physicians from many disciplines involved in tissue repair and stem cell research, cytokine investigators, cancer biologists and biotherapists.


Cytotherapy, Cytokine, Translational Research, Stem Cells, Cellular Therapies, Vaccines, Gene Therapy, Immunotherapy, Tissue Engineering, Blood and Bone Marrow, T cells.

Submission Details

Cytotherapy publishes original papers, reviews, novel hypotheses, short communications, book reviews and editorials. Submitted manuscripts will be reviewed by at least two reviewers. Authors will be notified within 30 working days of receipt whether the manuscript is accepted, requires revision or is rejected. All manuscripts will be published within five months from the date of acceptance. Contributors should submit manuscripts via:

CLICK HERE to access Cytotherapy

Associate Editors:


John Barrett, MD
Senior Editor
National Institutes of Health*
Bethesda, United States

*Dr. Barrett serves as Senior Editor in his personal capacity. The views expressed are his own and do not necessarily represent the views of the National Institute of Health or the United States Government.
1724 Webster St. NW, Washington, DC 20011


Catherine Bollard, MBChB, MD
Children's National Health System and the George Washington University
Washington, DC, United States
Massimo Dominici, MD
University of Modena and Reggio
Modena, Italy
Peiman Hematti, MD
University of Wisconsin-Madison School of Medicine & Public Health
Madison, WI, United States
Donald Phinney, PhD
The Scripps Research Institute
Jupiter, FL, United States
Katayoun Rezvani, MD, PhD
University of Texas MD Anderson Cancer Center
Houston, TX, United States
Royal Prince Alfred Hospital
Sydney, Australia



Editorial Advisory Board
The editors are supported by an international advisory board made up of over 35 eminent academics in the field.


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.